Delayed treatment with nicofinamide (Vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats

Stroke

Volumn 31, Issue 7, 2000, Pages 1679-1685

  Mokudai, Toshihiko ^b   Ayoub, Issam A ^a   Sakakibara, Yohtaro ^a   Lee, E Jian ^c   Ogilvy, Christopher S ^a   Maynard, Kenneth I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Energy metabolism; Middle cerebral artery occlusion; Neuroprotection; Niacinamide; Rats; Stroke

Indexed keywords

NICOTINAMIDE; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN INFARCTION; BRAIN ISCHEMIA; ENERGY METABOLISM; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT OUTCOME; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; DRUG EFFECT; METABOLISM; MORTALITY; MOTOR ACTIVITY; PATHOLOGY; TRANSIENT ISCHEMIC ATTACK; VASCULARIZATION; WEIGHT GAIN; WISTAR RAT;

ANIMALS; BRAIN; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; ENERGY METABOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NIACINAMIDE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0033623756     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1679     Document Type: Article

References (37)

1. Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions. J Cardiothorac Vasc Anesth. 1996;10:139-146.
2. Ames A III, Maynard KI, Kaplan S. Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J Cereb Blood Flow Metab. 1995;15:433-439.
3. Maynard KI, Kawamata T, Ogilvy CS, Perez F, Arango P, Ames A III. Avoiding stroke during cerebral arterial occlusion by temporarily blocking neuronal functions in the rabbit. J Stroke Cerebrovasc Dis. 1998;7:287-295.
4. Ayoub IA, Lee J, Ogilvy CS, Beal MF, Maynard KI. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats. Neurosci Lett. 1999;259:21-24.
5. 10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol. 1994;36:882-888.
6. Klaidman LK, Mukherjee SK, Hutchin TP, Adams JD. Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neurosci Lett. 1996;206:5-8.
7. Huang NK, Wan FJ, Tseng CJ, Tung CS. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats. Neuroreport. 1997;8:1883-1885.
8. Stephans S, Whittingham T, Douglas A, Lust W, Yamamoto B. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J Neurochem. 1998;71:613-621.
9. Jacob RA, Swendseid ME. Niacin. In: Ziegler EE, Filer LJ Jr, eds. Present Knowledge in Nutrition. 7th ed. Washington, DC: International Life Sciences Institute Press; 1996:184-190.
10. Wallis RA, Panizzon KL, Girard JM. Traumatic neuroprotection with inhibitors of nitric oxide and ADP-ribosylation. Brain Res. 1996;710: 169-177.
11. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30:2752-2758.
12. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, 1: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1-8.
13. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Stroke. 1996;27: 1616-1623.
14. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986; 6:1304-1308.
15. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski HM. Rat middle cerebral artery occlusion evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
16. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10:290-293.
17. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab. 1996;16:195-201.
18. Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation. 1998; 5:143-159.
19. Wan FJ, Lin HC, Kang BH, Tseng CJ, Tung CS. D-Amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res Bull. 1999;50:167-171.
20. Eliasson MJL, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang Z-Q, Dawson TM, Snyder SH, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med. 1997;3:1089-1095.
21. Endres M, Wang Z-Q, Namura S, Waeber C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab. 199 7;17:1143-1151.
22. Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1997;17:1137-1142.
23. Sun AY, Cheng JS. Neuroprotective effects of poly(ADP-ribose) polymerase inhibition in transient focal cerebral ischemia of rats. Chung Kuo Yao Li Hsueh Pao. 1998;19:104-108.
24. Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, Greenberg JH. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 1999;829: 46-54.
25. Williams L, Liang S, Lautar S, Li J-H, Zhang J. GPI-6150, a potent PARP inhibitor, reduces infarct size following permanent and transient focal cerebral ischemia. Soc Neurosci Abstr. 1999;25:1061. Abstract.
26. Zhang J, Dawson VL, Dawson, TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 1994;263: 687-689.
27. Endres M, Scott G, Namura S, Salzman AL, Huang PL, Moskowitz MA, Szabo C. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci Lett. 1997;248:41-44.
28. Lo E, Bosque-Hamilton P, Meng W. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of n-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke. 1998;29: 830-836.
29. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A. 1986;83:4908-4912.
30. Huang TF, Chao CC. The effect of niacinamide on cerebral circulation. Proc Soc Exp Biol Med. 1960;105:551-553.
31. Brown SL, Ewing JR, Kolozsvary A, Butt S, Cao Y, Kim JH. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration. Int J Radiat Oncol Biol Phys. 1999;43:627-633.
32. Kryzhanovskii GN, Shandra AA, Makul'kin RF, Lokasiuk BA, Godlevskii LS. Effect of nicotinamide on epileptic activity in the cerebral cortex. Biull Eksp Biol Med. 1980;89:37-41.
33. Braslavskii VE, Shchavelev VA, Kryzhanoskii GN, Nikushkin EV, Germanov SB. Effect of nicotinamide on focal and generalized epileptic activity in the cerebral cortex. Biull Eksp Biol Med. 1982;94:39-42.
34. Chumakov VN, Starchik TG. Effect of nucleotide anti-aggregants (NAD, AMP) and ischemia on the tissue blood coagulation factors. Gematol Transfuziol. 1991;36:9-13.
35. Morris PB, Ellis MN, Swain JL. Angiogenic potency of the nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol. 1989;21:351-358.
36. Green RG. Subclinical pellagra: its diagnosis and treatment. Schizophrenia. 1970;2:70-79.
37. Stratford MRL, Rojas A, Hall DW, Dennis MF, Dische S, Joiner MC, Hodgkiss RJ. Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers. Radiother Oncol. 1992;25:37-42.